I
nflammatory bowel disease (IBD) is a chronic and relapsing disorder of the gastrointestinal tract, which includes Crohn's disease (CD) and ulcerative colitis. The current therapies for CD based on immunosuppressive agents are not entirely effective and could result in multiple adverse effects. 1 Transplantation of mesenchymal stem cells (MSCs) has shown great therapeutic promise in IBD management due to its anti-inflammatory and reparative properties. [2] [3] [4] Depending on local environment, MSCs may give rise to many cell lineages including epithelial cells, astrocytes, osteoblasts, chondrocytes, adipocytes, and muscle, promoting regeneration of damaged tissue in vivo. 5 MSCs also induce peripheral tolerance and migrate to injured tissues, in which they can inhibit the release of proinflammatory cytokines and promote the survival of damaged cells. 5 MSC homing to injured tissue is critical to its regenerative and immunomodulatory benefits, and there is an urgent need to delineate the relative contribution to the regenerated tissues and organs from delivered cells versus host cells. 6 Several studies have indicated that the recruitment of MSC to inflamed tissue depends on CXC chemokine receptor 4, 7 platelets, 8 and other factors. 9 However, the clinically feasible methods demonstrating the recruitment of transplanted MSCs in vivo are still lacking, which hinder the translation of MSC research to clinical application.
The lingering problem in the field of cell-based therapies is how to deliver cells to the inflamed tissues efficiently. 10 This process is influenced by multiple factors, such as source and culture, delivery method, host receptability, and drugs. For example, donor-specific anti-HLA antibodies against allograft MSCs might develop with repeated infusions, particularly in patients with CD. 4 In such circumstances, further infusion of MSCs would be futile and cause adverse effects. Thus, it is imperative that we can trace the fate of the injected cells. And, it also requires the capability to distinguish intact cells to cell debris. To our best knowledge, there is no radiological method that can currently fulfill this goal. Also, the white light endoscopy and magnifying endoscopy were excluded for potential utility for their lack of capability to recognize cells.
Confocal laser endomicroscopy (CLE) is a clinically available tool that gives real-time optical sectioning images of cellular resolution similar to histology. Recent study indicated that endomicroscopic molecular imaging with fluorescent antibodies has the potential to predict therapeutic responses to biological treatment. 11 Endomicroscopy is performed at 488 nm illumination for excitation, and 505 to 585 nm detection for emission, 12 compatible with enhanced green fluorescent protein (eGFP) and cell labeling organic dyes. Its lateral resolution is 1 to 1.5 mm, enabling the identification of single labeled cells. In this study, we investigated the possibility of using endomicroscopy to track the fluorescence-labeled MSCs to the intestinal mucosa. The aim of this study, therefore, was to show the general feasibility of using endomicroscopy to visualize fluorescence-labeled MSCs ex vivo and monitor the MSC recruitment to intestinal mucosa in vivo. We also explored the value of endomicroscopy in noninvasively quantifying MSC recruitment to the recipient rat colonic mucosa in the rat bone marrow MSC allograft model, hypoxia-induced rat MSC (rMSC) model, busulfan preconditioned model, and human bone marrow MSC xenograft model.
MATERIALS AND METHODS

Animal Maintenance and Colitis Modeling
Sprague Dawley rats were purchased from Animal Center of Shandong University of Traditional Chinese Medicine. Their female littermate offspring were kept under standardized specific pathogen-free conditions (temperature, 218C-228C; illumination 12:12-hour light-dark cycle) with free access to pellet food and water ad libitum. All experiments were approved by Ethical Committee and Institutional Animal Care and Use Committee of Qilu hospital. Colitis was induced by giving female rats 8% DSS (MP biomedicals, Shanghai, China) with a molecular weight between 36,000 and 50,000 in drinking water for 5 days. The severity of colitis was assessed daily using a disease activity index, which assesses the following 3 parameters: weight loss, stool consistency, and the presence or absence of fecal blood. 13 
MSC Preparation, Characterization, and Labeling
Male rMSC was harvested and cultured as described previously.
14 Briefly, bone marrow cells were collected by inserting a needle into the shaft of the femurs and tibias and flushing it with 10 mL commercial optimized OriCell Spraqgue Dawley rat MSC growth medium (Cyagen, Guangzhou, China). The cells were grown in complete growth medium at 378C and 5% CO 2 . The medium was replaced with fresh medium every 2 days until the adherent cells were grown to 80% confluency to obtain samples defined as passage 0. Cells between passages 5 and 6 were used for experiments.
Prepared rMSCs were characterized according to the minimal criteria by the International Society of Cellular Therapy. 15 Adipogenesis and osteogenesis of MSCs were performed as previously described. 15 Immunophenotype of rMSCs was determined by FACS Calibur (BD Biosciences) with antibodies specific for rat surface antigens CD44, CD90, CD29, CD73, CD34, CD11b/c, and CD45 (Mesenchymal Stem Cell Characterization Kit, CAT# RAXMX-09011, Cyagen). 16 Data were analyzed by collecting 10,000 events on a BD FACS CALIBUR using FlowJo 7.6.1 software. Adipogenic, osteogenic, and chondrogenic differentiation potential were characterized using commercially optimized differentiation medium (CAT# RASMX-90031, RASMX-90021, RASMX-90041, respectively; Cyagen).
At passage 2, rMSCs were transfected with the lentiviral eGFP vector, which uses a CMV promoter (CAT# LV-EGFP-0201, Cyagen). The multiplicity of infection was 240. The infection efficiency and fluorescence intensity were analyzed by inverted fluorescent microscopy and flow cytometry. For in vivo imaging studies, the commercialized human-derived bone marrow MSC with lentiviral eGFP labeling (hMSC) was purchased from Cyagen (CAT# HUXMA-01001) and expanded in corresponding growth medium (CAT# HUXMA-90011, Cyagen). In the ex vivo imaging study, isolated MSC was incubated with 5 mM 5,6-carboxyfluorescein succinimidyl ester for 15 minutes 17 and then incubated in growth medium for 30 minutes before endomicroscopy.
Ex Vivo Endomicroscopic MSC Imaging
Ex vivo eGFP-labeled rMSC (eGFP-rMSC) was imaged by 2 types of endomicroscope, the FIVE1 system (Optiscan, Australia), and Cellvizio system (Mauna Kea Technologies, France), which were equivalent to the endoscope-based CLE and probe-based CLE, respectively. For the FIVE1 system, the lateral resolution was 0.7 mm, and image depth was adjustable from surface to 250 mm. 18 The field of view was 475 · 475 mm, and the laser power was set at 1000 mW. The Cellvizio system had a field of view of 240 mm, a lateral resolution of 1 mm, and an imaging depth of 60 mm below the tissue surface. MSCs were seeded in 6-well plates at a density of 2000 cells per square centimeter. Endomicroscope was vertically placed on the plates to image the cells, and the acquired data were stored in forms of still images (FIVE1) or videos (Cellvizio).
MSC Transplantation
MSCs were injected either intravenously or intraperitoneally in different experimental settings. For the intravenous experiment, 4 · 10 6 rMSCs in 1 mL phosphate-buffered saline (PBS) was injected into the lateral tail vein 6 hours after the beginning of DSS treatment. To ensure the validity of tail vein injection, we first intubated an indwelling venous needle (18 G Y type, BD, Shanghai) into the lateral tail vein. Then, the MSC was injected through this needle. The in vivo endomicroscopic imaging was performed at 24 hours after DSS treatment. Because intravenous injection often causes a high death rate of recipient rats, we did not use a larger does or inject repeatedly. Also, after seeing that both intravenous and intraperitoneal injections could deliver MSCs to be detected by endomicroscopy, we based the majority of this study on the intraperitoneal method.
For the intraperitoneal settings, at 6 hours (day 0), 2 and 4 days after the beginning of DSS treatment, 5 · 10 6 rMSCs in 1 mL PBS were each time intraperitoneally injected to rats (rMSC group). Control rats (Ctl group) were injected with 1 mL PBS to verify the specificity of endoscopic fluorescent signal. The injection and imaging time points was such set because several studies indicated that this time frame might be the suitable to access the MSC extrusion and migration to the inflamed tissues. 8, 17 In Vivo Endomicroscopic Imaging of Labeled MSCs
Because there was no currently available protocol to perform per anal endoscopy in rats, we have to examine the mucosa by laparotomy and exteriorization of the colon. Rats were fasted 24 hours before the in vivo imaging. After induced anesthesia, the rats' ascending and descending colonic mucosa was exteriorized by longitudinal incision along antimesenteric colonic wall. During these procedures, rat body temperature was maintained at 378C by a heating pad. For in vivo endomicroscopy, the handheld FIVE1 confocal probe was placed gently onto the colonic intestinal surface in a way to achieve full contact of the confocal imaging window with the tissue. The ascending and descending colon were each divided to 3 equal segments, and acquired images were stored per segment. In each segment, the colonic mucosa was imaged from the top surface to 20 planes deeper, with a step depth increment of 7 mm. The complete mucosa surface was screened with the confocal probe for fluorescent signal by carefully moving the probe across the mucosa while at the same time adapting imaging plane depth. The whole imaging process lasts 20 to 40 minutes and generates 800 to 2200 confocal images.
Immunofluorescence
After the imaging procedures, the first and third segments were fixed in 4% buffered formalin and frozen sectioned for immunofluorescence imaging. Frozen sections of 4 mm were blocked with 20% bovine serum albumin (CAT# A7030-25 G; Sigma, Shanghai, China) and sequentially incubated with 1:100 diluted Anti-GFP Tag Monoclonal Antibody (CAT# E022030-01, EarthOx, San Francisco, CA) and PE-labeled Goat Anti-Mouse IgG (4A biotech, Beijing, China). Our detection of engraved MSCs was based on the red PE immunofluorescence signal rather than the inherent fluorescence of eGFP protein.
Quantified Polymerase Chain Reaction
For quantified polymerase chain reaction (qPCR), we washed the colon specimen in PBS, and we peeled the mucosa to analyze the inner colonic surface that could be examined by in vivo endomicroscopy. And the second segment of ascending and descending rat colon was snap frozen and stored in 2808C until qPCR quantification. The total DNA was extracted from the colonic mucosa using TIANamp Genomic DNA Kit (DP304; Tiangen, Beijing, China). To build the standard curve, 10 6 mixed MSCs in which eGFP-rMSC accounts a serial number of 0, 10 1 , 10 2 , 10 3 , 10 4 , 10 5 , 10 6 per 10 6 cells, and its genomic DNA was extracted in the same manner as the mucosa tissue. Isolated DNA was analyzed for concentration and purity using NanoDrop 2000 (Thermo Scientific). Aliquots of 100 mg tissue or cell-derived DNA were analyzed by a real-time PCR assay. As described previously, 19 a 75 base-pair region of the eGFP transgene was amplified as previously described using the following primers and dual-labeled fluorescent probe: forward primer, 5
0 -ACT-ACAACAGCCACAACGTCTATATCA-3 0 ; reverse primer, 5 0 -GGCGGATCTTGAAGTTCACC-3 0 ; and Taqman probe:
Immunohistochemistry
Immunohistochemistry was performed on cryosections of recipient rat mucosa. The sections was blocked with normal donkey serum (CAT# ab7475; Abcam, Shanghai, China) for 1 hour and then incubated with polyclonal goat anti-eGFP first antibody (CAT# 6673, Abcam) and subsequently horseradish peroxidase-labeled donkey Anti-Goat IgG H&L (CAT# ab6885, Abcam). eGFP-positive cells were stained by the TMB horseradish peroxidase color development solution (CAT# P0211, Beyotime, Zhejiang, China).
Fluorescence In Situ Hybridization
Fluorescence in situ hybridization (FISH) of the chromosome Y was performed on cryosections of rat to which hMSC was transplanted. A mixture of 7 mL locus specific identifier, 1 mL fluorescent probe of chromosome Y (CAT#05J27-089; Vysis, IL), and 2 mL deionized water was added to each pretreated section. All FISH procedures were performed according to the manufacturer's instruction except that the incubation time in 378C was 48 hours.
In Vivo Imaging in Multiple Models
To explore whether endomicroscopy could track labeled cell under varied conditions, we compared the in vivo endomicroscopic images of the colonic mucosal MSCs in 3 more groups. In the hypoxia group (HOX group, n ¼ 2), the cells incubated for 48 hours in 2% O 2 before transplantation. In the busulfan preconception group (BU group, n ¼ 2), an enhanced MSC homing model with bone marrow hypoplasia was induced by a single intraperitoneal dose (20 mg/kg) busulfan (1,4-butanediol dimethanesulfonate, BU) to the recipient rat 1 day before 5-day 4% DSS treatment. 20 Because the 8% DSS would be fatal for the BU group, we used 4% instead for this group. In the xenograft group (hMSC group, n ¼ 2), we transplanted the commercialized eGFPlabeled human-derived bone marrow MSC to the recipient colitis rat. Littermate female rats weighed 153 to 198 g (median, 186 g) were randomly allocated to the above groups. The dosage, intraperitoneal injection time, and the imaging method were all identical to that of the rMSC group described above.
Computer-aided Stem Cell Counting
To endomicroscopically examine the interested region, it would often give hundreds of still images that exceed the handing capacity of endoscopists. Therefore, we developed an automatic MSC counting program using automatic threshold segmentation and shape recognition algorithm in MATLAB (MathWorks). We empirically determined that MSCs should have a minimal brightness of 50 (0-255 for 8-bit grayscale images), area between 50 and 350 pixels, and eccentricity lower than 0.9. The MSCs recognized by computer were automatically counted and marked by green bounding boxes and further underwent manual review to ensure the correctness. The frequency of visualized MSCs per 100 acquired images was calculated for each rat. The MSC frequency between groups was compared using the Kruskal-Wallis test or Student's t test in the SAS V.9.3 statistical software.
RESULTS
MSC Preparation and eGFP Labeling
We extracted and characterized rMSC from female Sprague Dawley rats. Immunophenotype and the differentiation capacity of rMSC isolates were consistent with those of previous reports. (Fig. 1D) . Of note, 73.8% of MSCs transduced with eGFP lentivirus was green fluorescent positive.
Ex Vivo Endomicroscopic Imaging of MSCs
We first tested ex vivo MSC imaging capability using 2 types of currently available endomicroscope, the FIVE1 system (Optiscan, Australia) and Cellvizio system (Mauna Kea Technologies, France). Ex vivo rMSCs show different characteristic depending on the labeling method. The eGFP-labeled rMSC has brighter nucleus than the cytoplasm, as demonstrated in fluorescent microscopic and endomicroscopic (FIVE1) images (Fig. 1) . Furthermore, the fluorescent intensity of eGFP-MSC nucleus was heterogeneous, and some fluorescent dense mass could be visualized within each nucleus. The cytoplasm of carboxyfluorescein succinimidyl ester-labeled MSC was brighter than its nucleus. This was possibly due to the different labeling mechanisms. As described previously, 21 the GFP translocates to the nucleus spontaneously due to unspecific diffusion of the relatively small GFP through the nuclear pores whereas the carboxyfluorescein succinimidyl ester reacts with cytoplasmic amines, forming fluorescent conjugates, which may explain its relatively higher concentration in cytoplasm. The FIVE1 endomicroscopic images correlated well with fluorescent microscopic images. When using the Cellvizio endomicroscope to image MSCs ex vivo, the above features were not prominent. This was probably due to inferior resolution and fixed imaging depth of Cellvizio system.
In Vivo Endomicroscopic Imaging of MSCs
After validating the endomicroscope capability of tracking fluorescently labeled MSCs ex vivo, we investigated whether it could track the MSC recruitment to the mucosa in vivo, which is of significant clinical potential for the MSC translational medicine. We transplanted a total of 1.5 · 10 7 eGFP-labeled rMSC (at 6 h, day 2, and day 4) to the intraperitoneal group (n ¼ 4) and 4 · 10 7 (at 6 h) to the intravenous group (n ¼ 2). At 24 hours after the last dose, we endomicroscopically examined their colonic mucosa using a FIVE1 endomicroscope. A typical image was shown in Figure 2A (intraperitoneal) and Figure 2B (intravenous), where the prominent round nucleus but not the cytoplasm was visible. In the healthy control rats (n ¼ 3) or DSS colitis rats (n ¼ 7), we could not find any labeled nucleus (Fig. 2C, D) . Similar to the ex vivo images, the in situ eGFP-MSC nucleus showed a heterogeneous internal intensity. Adjusting the image depth during the in vivo endomicroscopy was necessary to identify MSCs. We characterized in situ MSCs in vivo at a series of continuous depth, showing that the nucleus was visible at most 7 consecutive endomicroscopic imaging planes (Fig. 2E) . We could hardly detect any fluorescent signal of eGFP-MSC using the Cellvizio endomicroscope, even at the identical site immediately after FIVE1 imaging (data not shown). From the above results, we summarized the characteristics of eGFP-labeled MSCs on in vivo endomicroscopic images as follows:
1. Round and nucleus of a diameter ranged from 5 to 10 mm. 2. Heterogeneous fluorescent intensity within the nucleus. 3. Fluorescent intensity abates when imaging plane deviate from the stem cells.
We noticed significant difference between endomicroscopic images of transplanted rMSC on inflamed mucosa of the colitic rats and that of cultured cells on the disc. The cytoplasma cytoplasm of cultured eGFP-rMSC was visible ex vivo, but it was invisible in vivo, which could be caused by cellular morphology difference between ex vivo and transplanted cells (Fig. 2F) . The ex vivo MSC was flat on the plastic surface and spread within the image plane of the endomicroscope. While whereas the in vivo MSC on the colonic mucosa surface was integrated into the tissue structure, and its cytoplasmcytoplasma could hardly fall within the endomicroscopic imaging plane. Therefore, the round bright and heterogeneous nucleus was the hallmark of eGFP eGFPlabeled MSC in endomicroscopic images.
We also found that labeled MSCs could also be found in the ilium mucosa (Fig. 2G) , and there were remaining MSCs in the peritoneum (Fig. 2H ) of recipient rat. But by using an endomicroscope, we could not find any MSCs on the surface of liver, kidney, or pancreas (data not shown). Neither could we find any signal from the lung immediately after the euthanasia. However, we could not exclude the existence of transplanted MSCs in these organs because endomicroscope could only image very superficially and is not suitable to image these organs externally. We did not try to image in the circulation because red blood cells normally block the excitation lights of endomicroscope.
Comparing in Vivo Endomicroscopy with Histology and PCR
We next examined the presence of transplanted MSCs in the superficial colonic mucosa using traditional laboratory methods (Fig. 3) . As previously described, 22 the autofluorescence of transverse section of recipient rat colonic mucosa demonstrated a mix of nonspecific autofluorescence and eGFP signal. We then used mouse anti-eGFP antibody and secondary PE-labeled goatanti-mouse IgG to detect eGFP immunologically. Isolated eGFPpositive cells were present in the colonic mucosa of recipient rats, as their overlapping weak inherent green fluorescence and the intensive red PE signal were detected, corresponding to endomicroscopy (Fig. 3A) .
We also examined the rMSCs on the mucosal surface using immunohistochemistry method. Isolated eGFP-positive cells were stained positively on the colonic mucosa of recipient rats (Fig. 3B) . FISH examination was done on the recipient colonic mucosa that received human MSCs (Fig. 3C) . Both the immunohistochemistry and FISH images correlated to the endomicroscopic images. FIGURE 1. Ex vivo imaging of eGFP-(left column) or CFSE-labeled MSC (right column) using fluorescent microscopy (top), FIVE1 endomicroscopy (middle), and Cellvizio endomicroscopy (bottom). The eGFP-labeled MSCs have brighter nucleus than the cytoplasm, due to the spontaneous nuclear localization of eGFP (white arrows), whereas the cytoplasm of CFSE-labeled MSCs is brighter than the nucleus (white arrow head). CFSE, carboxyfluorescein succinimidyl ester.
We then compared the MSC quantification capability between in vivo endomicroscopy and quantitative PCR. To test the performance of qPCR in vitro, we made 6 standard mixes of eGFP-rMSC with unlabeled rMSCs in a serial ratio. We could detect 100 eGFP-positive cells diluted in total 10 6 cells, but 10 in 10 6 failed to be detected (Fig. 2D) . We could not detect any MSCs in colonic mucosa by qPCR, suggesting that in vivo endomicroscopy is more sensitive than qPCR to track the stem cells in vivo. . (E), Consecutive endoscopic images of eGFP-MSCs at a series of depth on the rat colonic mucosa of the intraperitoneal group. One eGFP-MSC was at most 7 layers visible when adjusting the image. The first column was the original images, and the second column was adjusted 40% brighter to facilitate the characterization of eGFP-MSC. (F), Schematic explanation of the endomicroscopic differences of eGFP-MSC between in vivo and ex vivo imaging. Due to the spatial orientation of eGFP-MSC in vivo, the cytoplasm was invisible and the nucleus was smaller compared with that on the ex vivo images. Labeled cells could also be visualized in the endomicroscopic images from the ilium mucosa (G) and peritoneum (H) of the intraperitoneal recipient rat. The arrows indicate eGFP-labeled cells, and the asterisks indicate fat granules which are darker than the background.
Tracking MSCs Under Varied Conditions
Next, we investigated whether in vivo endomicroscopy could track the stem cell in verified conditions. We permuted the transplantation conditions by hypoxia induction of the rMSC, immunosuppression of the recipient rats, or injecting the humanderived MSCs instead of rMSCs to the colitic rats. Consistent with previous reports, 23, 24 compared with the normoxia rMSCs (Fig. 4A) , the frequency of rMSCs was higher in the hypoxia group in which the rMSC was incubated 2% hypoxia for 48 hours before intraperitoneal injection (Fig. 4B) . When the recipient colitic rats were given 20 mg/kg busulfan, an immunosuppressive reagent, 1 day before 4% DSS induction of colitis, we found a marginal increase of total MSCs homed to the mucosa (Fig. 4B) . We also detected the presence of hMSC on the rat colonic mucosa (Fig. 4D ) using in vivo endomicroscopy. These suggested that endomicroscopy could quantify the frequency of MSCs on the colonic mucosa under varied conditions.
We also developed a MATLAB-based program (MathWorks) to facilitate automatic MSC counting from hundreds of images generated in 1 endomicroscopy procedure. Using the automatic threshold segmentation and shape recognition algorithm, the MSCs could be automatically detected and counted by the computer. MSCs recognized by this algorithm were marked by green bonding boxes (Fig. 4A-D lower right insertion) to facilitate stem cell counting. Thus, we were able to view more than 500 endomicroscopic images within 10 minutes. This algorithm recognized more labeled cells in MSC-infused group (rMSC + BU + hMSC + HOX, n ¼ 10) than the non-MSC group (Ctl + DSS, n ¼ 10) significantly (Kruskal-Wallis test, P ¼ 0.0099; Fig. 4E ). In the HOX group (n ¼ 2), the density of mucosal MSC on the endomicroscopic images tended to be higher than other groups combined (rMSC + BU + hMSC, n ¼ 8) but failed to reach the statistical significance (114.1 versus 34.3, t ¼ 2.14, P ¼ 0.0644, Fig. 4F ).
Relocating the Labeled Cells
We also tested whether the endomicroscopically located MSCs could be relocated after a time frame of about 5 minutes. Figure 5A shows endomicroscopic images from the HOX group. And, when we relocate these clusters of cells using endomicroscope, we got Figure 5B . Comparing these 2 images, we found that the relative locations of 3 major clusters remain the static (as indicated by dashed box, ellipse, and triangles). But the image contrast reduced, and the labeled MSCs became obscure. We infer that this was caused by the edema of the exteriorized mucosa (also for this reason, we did not relocate after longer interval).
DISCUSSION
This study demonstrated that eGFP-labeled MSCs that travel to the recipient colonic mucosa could be imaged by endomicroscopy in vivo. Here, we used the DSS colitis and MSC intraperitoneal injection model to test the in vivo imaging capability of the endomicroscopy for fluorescently labeled cells. The property of this model has been documented by many other papers. 17, 25 Manuel et al have shown that adipose-derived MSCs could be recruited to the inflamed colon with a maximum density at the third day after intraperitoneal injection, and it was more efficient than to the noninflamed colon. 17 Also, hypoxia preconditioning was documented to enhance MSC viability in vivo. 25 Here, using endomicroscope, we could found the MSC on the recipient colonic mucosa and the frequency of MSC tend to be higher in the hypoxia preconditioned group. Our endomicroscopic results were consist with these findings and suggested that it might be a clinical available tool to track the infused MSCs in vivo.
Currently, the use of MSC in the therapy of IBD is being investigated in patients, but many factors, such as drugs, genetic background, and disease activity, may affect the MSC recruitment to the colorectal mucosa. Thus, the recruitment of MSC to the colorectal mucosa needs to be documented personally. It has been FIGURE 4. Tracking the labeled cells in varied conditions using endomicroscopy. The frequency of eGFP-labeled MSC was endomicroscopically evaluated on rats that receive normoxia (A) or hypoxia (B) induced rMSC, on busulfan preconditioned rats (C), and on rats that received hMSC (D). The lower left box shows the regional magnification in the dashed box. The lower right box demonstrates that the MSC was automatically recognized and marked by a green bounding box to assist MSC counting. (E), The MSC counting program yield higher MSC frequency in the recipient rats than the nonrecipient rats (Kruskal-Wallis test P ¼ 0.0099). (F), The mean frequency of MSC per 100 images. In the HOX group (n ¼ 2), the frequency of mucosal MSC on the endomicroscopic images tended to be higher than other groups combined (rMSC + BU + hMSC, n ¼ 8) without statistical significance (114.1 versus 34.3, t ¼ 2.14, P ¼ 0.0644).
shown that the metabolism of infused MSCs is regulated by the host immunological status. 26 In patients with IBD, conventional therapy, such as corticosteroids and immunosuppressant drugs, often affects the patients' immune responses to more diverse status. Thus, noninvasively tracking the infused cells using endomicroscopy might be informative to individualize the MSC therapeutic regimen.
Radiological approaches have been previously explored to noninvasively track infused stem cells in vivo. The utility of magnetic resonance imaging to trace superparamagnetic particles labeled MSCs was extensively studied. [27] [28] [29] [30] Although magnetic resonance imaging could demonstrate the global distribution of MSCs across the different organs, it could not distinguish live MSC from dead cell debris containing the labeling material. Furthermore, magnetic resonance imaging could not adequately image the intestine due to the peristalsis within 1 imaging frame. 31 Single-photon emission computed tomography/X-ray computed tomography could also track MSCs with similar performance, but the labeling with indium-111 oxine may impair MSC's functional integrity. 31 Neither of these radiological methods could track stem cells in a cellular resolution. Here, we explored the endoscopic approach for the first time, using the endomicroscope in combination of the eGFP labeling, to noninvasively track MSCs in the colonic mucosa. There are 3 major advantages of this approach: first, the endomicroscope can provide ultra highresolution images that illustrate each individual labeled cell in the intestinal mucosa. This excludes the possibility of mistaking cell debris as live stem cells; second, compared with the biopsy-based laboratory methods (like PCR or Western blot), tracking MSC by endomicroscopy is completely noninvasive and will save unnecessary biopsies on the patients. Furthermore, from an economic review, endomicroscope can simultaneously evaluate the disease status (using white light mode or endomicroscopically) and tracking stem cells in the patients.
Currently, there are several methods to add fluorescence to MSCs for in vivo tracking. Organic dyes are easy to use, relatively inexpensive, and are capable of labeling cells in culture for short time. However, organic fluorophores may photobleach and lose fluorescence and therefore are not typically used to label cells for substantial time. 32 Genetically encoded fluorescent proteins such as eGFP are typically transfected into the cells through retrovirus, lentivirus, or nonviral approaches. They have better photostability and pH tolerance in addition to longer luminescence time. However, GFPs suffer from intrinsic deficiencies such as sensitivity to proteolytic enzymes. 33 Another fluorescent labeling material, quantum dots (QDs), is with their emission and excitation spectra that can be fine-tuned. QDs are generally photostable and maintain fluorescent intensity for a prolonged time.
QDs are approximately 10 to 20 times brighter than fluorescent proteins. 34 Here, we demonstrated the perfect capability of endomicroscope to specifically pick up the fluorescent signal from rat colonic mucosa. The compatibility of endomicroscopy with other cell labelling methods, such as the QDs, needs to be further tested.
There are several limitations that merit discussion in this study. First, the in vivo phenotype and function of transplanted MSCs could not be determined using endomicroscopy. We could not know whether the labeled cells had differentiated to myofibroblasts or retained its stem cell potential after the recruitment to the colonic mucosa. This may be overcome in the future by better endomicroscope resolution and the combination with in vivo molecular imaging. 35 Then, we could not know the exact path that the MSC migrate to the colonic mucosa. Previous study documented that MSC was also recruited to other organs such as spleen and mesenteric lymph node. 17 These sites were beyond the scope of endomicroscopy. Furthermore, all in vivo endomicroscopy experiments were done on exteriorized colons in this study because (1) the FIVE1 probe could not pass through the anus in this rat model sets, (2) we could hardly detect any fluorescent signal of eGFPMSCs using the thinner Cellvizio endomicroscope. This may less effectively model how this technique would be used in human patients. Also, the principles validated in animal models may not be directly transformed to human. Further studies evaluating the feasibility and potential benefits of endomicroscopically monitoring MSC using clinical type endomicroscope in larger animal models and human were warranted. In conclusion, we demonstrated in this study that endomicroscopy is a novel and promising tool to track transplanted MSCs in colonic mucosa. This clinical available noninvasive cellular tracking strategy may be informative to individualize each recipient's regimen and thus may streamline the stem cell therapy in the future clinical practice.
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